Skip to main content
Fig. 2 | Cancer Cell International

Fig. 2

From: Midazolam exhibits antitumour and enhances the efficiency of Anti-PD-1 immunotherapy in hepatocellular carcinoma

Fig. 2

MDZ inhibited migration in HCC cell lines. A–D Wound healing assays were used to assess the migration of HCC cells treated with MDZ for 24 h and 48 h. The left panel shows HCC-LM3 and Hep-3B cell migration after MDZ treatment. The right panel shows the cell migration rate. **P < 0.01, ***P < 0.001, ****P < 0.0001

Back to article page

Cancer Cell International

ISSN: 1475-2867

Contact us